These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10673818)

  • 1. Selective serotonin reuptake inhibitor-induced mydriasis.
    Larson M; Folstein S
    J Am Acad Child Adolesc Psychiatry; 2000 Feb; 39(2):138-9. PubMed ID: 10673818
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-sensitivity between paroxetine and sertraline.
    Warnock CA; Azadian AG
    Ann Pharmacother; 2002 Apr; 36(4):631-3. PubMed ID: 11918512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
    Sanchez C; Reines EH; Montgomery SA
    Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An imperfect literature and evidence-based medicine.
    Freeman MP
    J Clin Psychiatry; 2009 Mar; 70(3):412-3. PubMed ID: 19317958
    [No Abstract]   [Full Text] [Related]  

  • 5. Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.
    Schmitt JA; Ramaekers JG; Kruizinga MJ; van Boxtel MP; Vuurman EF; Riedel WJ
    J Psychopharmacol; 2002 Sep; 16(3):207-14. PubMed ID: 12236626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
    Kennedy SH; Eisfeld BS; Dickens SE; Bacchiochi JR; Bagby RM
    J Clin Psychiatry; 2000 Apr; 61(4):276-81. PubMed ID: 10830148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
    Fava M; Judge R; Hoog SL; Nilsson ME; Koke SC
    J Clin Psychiatry; 2000 Nov; 61(11):863-7. PubMed ID: 11105740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    Moore ML; Eichner SF; Jones JR
    Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic antidepressants and urinary incontinence.
    Votolato NA; Stern S; Caputo RM
    Int Urogynecol J Pelvic Floor Dysfunct; 2000 Dec; 11(6):386-8. PubMed ID: 11147747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.
    Sheffield RE; Lo Sasso AT; Young CH; Way K
    Adm Policy Ment Health; 2002 Nov; 30(2):121-39. PubMed ID: 12680617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Term Safety of Paroxetine and Sertraline in Breastfed Infants: A Retrospective Cohort Study from a University Hospital.
    Uguz F; Arpaci N
    Breastfeed Med; 2016 Nov; 11():487-489. PubMed ID: 27575664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 15. Paroxetine-induced somnambulism.
    Kawashima T; Yamada S
    J Clin Psychiatry; 2003 Apr; 64(4):483. PubMed ID: 12716257
    [No Abstract]   [Full Text] [Related]  

  • 16. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Violent parasomnia associated with a selective serotonin reuptake inhibitor: a case report.
    Khawaja IS; Hurwitz TD; Schenck CH
    J Clin Psychiatry; 2008 Dec; 69(12):1982-3. PubMed ID: 19203482
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose sertraline-induced erythema multiforme in a child.
    Khan MA; Fitzgerald K
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):179-80. PubMed ID: 22364401
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Mandrioli R; Mercolini L; Saracino MA; Raggi MA
    Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertraline-induced galactorrhea: case report and review of cases reported with other SSRIs.
    Nebhinani N
    Gen Hosp Psychiatry; 2013; 35(5):576.e3-5. PubMed ID: 23260337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.